Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
Open Access
- 8 January 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (1) , e0210330
Abstract
The aim of the present study was to assess the estimated “per patient” total cost for a single Oncologic Italian Cancer Center participating in a multicenter clinical trial with new anticancer biological agents using the activity-based costing (ABC) methodology. Nine randomized phase 3 clinical trials employing biological agents at the National Cancer Institute of Napoli, Italy, were analyzed to indentify “per patient” costs of each trial, according to the ABC methodology. The average consumption of resources for a patient completing the entire planned treatment was estimated for each trial. Through interviews of the personnel (doctors, nurses and technicians) and by analyses of the clinical trials protocols, the main activities of the 9 clinical trials were identified and, for each trial, the complete health care pathway of the patients and the treatment programmes were minutely reconstructed. Drug costs were not included because provided by Sponsors. The average costs of the pre-study, treatment, monitoring, follow-up, audit, and administrative activities accounted for 2.357, 4.783, 700, 372, 1.263, and 9 Euro, respectively. The average total cost estimated for all “per patient” activities, including overhead costs, was 11.379 Euro. Staff costs accounted for € 5.988, while costs of diagnostic test accounted for 3.494 Euro. Clinical trials with immunotherapeutic drugs accounted for higher costs (+601 Euro as oncological staff costs, +1.318 Euro as intermediate services cost and +384 Euro as overheads). The average total cost estimated for all “per patient” activities of a clinical trial with new anticancer biological agents was 11.379 Euro using the ABC methodology.Keywords
This publication has 12 references indexed in Scilit:
- Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item listJournal of Clinical Epidemiology, 2018
- Key cost drivers of pharmaceutical clinical trials in the United StatesClinical Trials, 2016
- Using Activity‐Based Costing in SurgeryAORN Journal, 2004
- The Costs of Conducting Clinical ResearchJournal of Clinical Oncology, 2003
- Activity-based costing: a practical model for cost calculation in radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Clinical Process Analysis and Activity-Based Costing at a Heart CenterJournal of Medical Systems, 2002
- Activity-based costing for hospitals.1996
- Activity-Based Costing for HospitalsHealth Care Management Review, 1996
- Improving hospital cost accounting with activity-based costing.1993
- Improving hospital cost accounting with activity-based costingHealth Care Management Review, 1993